Zhang Zheng, Wang Hui-Min, Xu Zhen-Xi, Luan Wen-Yu, Lin Si-Xiang, Miao Yan-Dong
Cancer Center, Yantai Affiliated Hospital of Binzhou Medical University, The Second Medical College of Binzhou Medical University, Yantai 264100, Shandong Province, China.
Research and Translational Center for Immunological Disorders, Binzhou Medical University, Yantai 264100, Shandong Province, China.
World J Gastrointest Oncol. 2025 Jun 15;17(6):107382. doi: 10.4251/wjgo.v17.i6.107382.
The rapid advancement of single-cell sequencing (SCS) technology has provided new insights into the relationship between inflammatory bowel disease (IBD) and colorectal cancer (CRC). This technique allows for detailed cellular analysis, enabling researchers to uncover the infiltration patterns of immune cells within the gut microenvironment and their roles in disease progression. This review summarizes significant research findings on the interplay between IBD and CRC, the characteristics of immune cell infiltration, and potential therapeutic targets identified through SCS. The aim is to offer references for future clinical studies and treatment strategies in this field.
单细胞测序(SCS)技术的迅速发展为炎症性肠病(IBD)与结直肠癌(CRC)之间的关系提供了新的见解。这项技术能够进行详细的细胞分析,使研究人员能够揭示肠道微环境中免疫细胞的浸润模式及其在疾病进展中的作用。本综述总结了关于IBD与CRC之间相互作用、免疫细胞浸润特征以及通过SCS确定的潜在治疗靶点的重要研究发现。目的是为该领域未来的临床研究和治疗策略提供参考。